Kailera secures $600M

Bain Capital Private Equity led Kailera Therapeutics' Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly's blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera's pipeline.

Editor's Pick

Top Story Kailera Secures $600M to Advance Dual-Targeting Obesity Drug to Global Phase 3 Tests Bain Capital Private Equity led Kailera Therapeutics' Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly's blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera's pipeline. Sponsored Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare Presented by Veradigm This essential guide explores how embracing a data-centric approach, powered by advanced analytics, AI, and interoperability, can fundamentally transform your organization: Streamline Workflows and slash administrative costs. Close Care Gaps by turning raw data into actionable insights. Improve Financial Performance and thrive in a competitive landscape.

Featured News

As Employers Face Spike in Healthcare Costs, How Can They Optimize Digital Health in Benefit Design? [Sponsored] Solera Health Chief Strategy Officer Ed Liebowitz and Premera Health Vice President of Product Nathan Johnson exchanged ideas in a robust discussion moderated by MedCity News Editor in Chief Arundhati Parmar.  AI Investment Is Now Driven by Proof Rather than Promise Investors, health systems and payers have grown more selective about AI startups in recent years, according to a panel of experts speaking at MedCity News' INVEST Digital Health conference. Customers and investors alike are now demanding clear evidence of ROI before committing to deals or partnerships. WellTheory Raises $14M to Expand Autoimmune Care Platform WellTheory's Series A round was led by General Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer and Up2 Opportunity Fund. Kailera Secures $600M to Advance Dual-Targeting Obesity Drug to Global Phase 3 Tests Bain Capital Private Equity led Kailera Therapeutics' Series B financing, which will support global Phase 3 tests of KAI-9531, a weekly injectable drug that hits the same targets as Eli Lilly's blockbuster obesity medication, Zepbound. The capital will also support development of other oral and injectable metabolic medicines in Kailera's pipeline. Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity. Meeting Patients Where They Are: A Smarter Path to Financial Health for Providers Organizations that meet patients where they are financially, digitally, and emotionally are the ones best positioned to support patients in managing their bills while strengthening trust, satisfaction, and long-term loyalty.

Video   Healthcare Isn't Always Designed with Women in Mind Historically, many medical products and practices have been designed around the male anatomy or physician convenience rather than women's needs, pointed out Abbie Clary, executive director of health for all at CannonDesign. She cited examples like artificial hips that fail more often in women, as well as CPR mannequins modeled on the male anatomy. There's also the fact that most childbirths take place with the woman on her back — a practice that prioritizes the doctors' ease over women's comfort and physiology.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and More MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed whether bitcoin would play a greater role in healthcare deals and the Trump administration's mixed messages on autism and Tylenol. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe